Data / Form D filings / Echo Therapeutics, Inc.
Echo Therapeutics, Inc.: Form D filings
Echo Therapeutics, Inc., a biotechnology company in Iselin, NJ, filed 9 Form D notices with the SEC between 2009 and 2016. The latest, on February 8, 2016, reports $1.8 million sold of a $6 million offering to 15 investors.
Find out what Echo Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 99 Wood Avenue South, Suite 302, Iselin, NJ, 08830
- Phone
- (732) 201-4189
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1031927
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 8, 2016 | New notice | $6,000,000 | $1,787,000 | $4,213,000 | 15 | Jan 29, 2016 | sec.gov |
| Dec 19, 2013 | New notice | $10,000,000 | $10,000,000 | $0 | 4 | Dec 10, 2013 | sec.gov |
| Feb 15, 2011 | New notice | $3,506,000 | $3,506,000 | $0 | 3 | Feb 8, 2011 | sec.gov |
| Feb 15, 2011 | Amendment | $3,000,000 | $2,896,500 | $103,500 | 46 | Nov 4, 2010 | sec.gov |
| Nov 5, 2010 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
| Oct 21, 2010 | New notice | $5,000,000 | $2,455,126 | $2,544,874 | 38 | Feb 9, 2010 | sec.gov |
| Dec 7, 2009 | New notice | $562,500 | $562,500 | $0 | 9 | Dec 3, 2009 | sec.gov |
| Nov 20, 2009 | New notice | $3,600,000 | $3,011,320 | $588,680 | 8 | Nov 13, 2009 | sec.gov |
| Jul 28, 2009 | New notice | $2,006,031 | $2,006,031 | $0 | 1 | Jul 7, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Scott W. Hollander | Executive Officer, Director | |
| Alan W. Schoenbart | Executive Officer | |
| Michael M. Goldberg | Director | |
| Elazer R. Edelman | Director | |
| Shepard M. Goldberg | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Feb 8, 2016 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Echo Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.